US029 — New York, New York

US029 is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

US029 has participated in 2 clinical trials.

Therapeutic areas: Alzheimer's Disease.

Sponsors: H. Lundbeck A/S.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US029?

US029 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US029 conducted?

US029 has 2 clinical trials on record. Their work covers Alzheimer's Disease.

Is US029 accredited by Crixeo Health?

US029 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US029?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.